Crossmark

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

Crossref DOI link: https://doi.org/10.1186/s12876-020-01247-6

Published Online: 2020-05-05

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hoffmann, Sabine

Crispin, Alexander

Lindoerfer, Doris

Sroczynski, Gaby

Siebert, Uwe

Mansmann, Ulrich

Consortium, FARKOR
License Information

Text and Data Mining valid from 2020-05-05

Version of Record valid from 2020-05-05
More Information

Article History

Received: 13 May 2019

Accepted: 27 March 2020

First Online: 5 May 2020

Ethics approval and consent to participate

: The institutional review board of the Medical Faculty of the Ludwig-Maximilians University, Munich, Germany have given ethics approval for this study (18-545). Informed written consent will be collected from the study participants by participating physicians.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below